Arkolith/Insider Trading/RUBY/Form 4

Appelhans Dannielle

CEO and PresidentRubius Therapeutics, Inc. (RUBY) · full profile →Form 4 · filed Feb 1, 2023
Net Selling
Open-Market Buys
$0
Open-Market Sells
$970
Net Open-Market Flow
-$969
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 1, 2023Sell(S)4K$0.25$97010K
Jan 31, 2023Option exercise(M)8K——14K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 31, 2023Option exercise(M)8K—$023K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-23-009464) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML